{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T01:25:42Z","timestamp":1787275542844,"version":"build-2736575974"},"reference-count":94,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","contactlensjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.clae.2024.102246","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T22:31:28Z","timestamp":1718231488000},"page":"102246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Absorption and attachment of atropine to etafilcon A contact lenses"],"prefix":"10.1016","volume":"47","author":[{"given":"Md","family":"Abdullah Aziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kuppusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishor","family":"Mazumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furqan","family":"Maulvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Willcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clae.2024.102246_b0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41572-020-00231-4","volume":"6","author":"Baird","year":"2020","journal-title":"Myopia Nat Rev Dis Primers"},{"issue":"10","key":"10.1016\/j.clae.2024.102246_b0010","first-page":"2211","article-title":"Axial length, anterior chamber depth-a study in different age groups and refractive errors","volume":"7","author":"Bhardwaj","year":"2013","journal-title":"J Clin Diagn Res"},{"issue":"4","key":"10.1016\/j.clae.2024.102246_b0015","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/cxo.12839","article-title":"Myopia and orthokeratology for myopia control","volume":"102","author":"Cho","year":"2019","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.clae.2024.102246_b0020","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/bmj.324.7347.1195","article-title":"Myopia","volume":"324","author":"Fredrick","year":"2002","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.clae.2024.102246_b0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/ICL.0000000000000677","article-title":"Biological mechanisms of atropine control of myopia","volume":"46","author":"Upadhyay","year":"2020","journal-title":"Eye Contact Lens"},{"issue":"12","key":"10.1016\/j.clae.2024.102246_b0030","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia","volume":"113","author":"Chua","year":"2006","journal-title":"Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2024.102246_b0035","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1038\/s41598-018-20272-w","article-title":"A highly efficient murine model of experimental myopia","volume":"8","author":"Jiang","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.clae.2024.102246_b0040","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10792-020-01658-0","article-title":"Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children","volume":"41","author":"Zhao","year":"2021","journal-title":"Int Ophthalmol"},{"issue":"6","key":"10.1016\/j.clae.2024.102246_b0045","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaophthalmol.2015.0471","article-title":"Prediction of juvenile-onset myopia","volume":"133","author":"Zadnik","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2024.102246_b0050","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmol"},{"issue":"11","key":"10.1016\/j.clae.2024.102246_b0055","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s00417-018-4112-8","article-title":"Short-term effects of low-concentration atropine eye drops on pupil size and accommodation in young adult subjects","volume":"256","author":"Kaymak","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"35\u201336","key":"10.1016\/j.clae.2024.102246_b0060","first-page":"575","article-title":"Preventing myopia","volume":"114","author":"Lagr\u00e8ze","year":"2017","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"10.1016\/j.clae.2024.102246_b0065","doi-asserted-by":"crossref","first-page":"M20","DOI":"10.1167\/iovs.18-25957","article-title":"IMI - defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies","volume":"60","author":"Flitcroft","year":"2019","journal-title":"Invest Ophthalmol vis Sci"},{"key":"10.1016\/j.clae.2024.102246_b0070","article-title":"Corneal penetration of low-dose atropine eye drops","volume":"10(4):588","author":"Austermann","year":"2021","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.clae.2024.102246_b0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmol"},{"issue":"9","key":"10.1016\/j.clae.2024.102246_b0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/jcm7090259","article-title":"The synergistic effects of orthokeratology and atropine in slowing the progression of myopia","volume":"7","author":"Wan","year":"2018","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.clae.2024.102246_b0085","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","article-title":"Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in Chinese children: a randomized clinical trial","volume":"138","author":"Wei","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"10.1016\/j.clae.2024.102246_b0090","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/jamaophthalmol.2023.2097","article-title":"Efficacy and safety of 0.01% and 0.02% atropine for the treatment of pediatric myopia progression over 3 years: a randomized clinical trial","volume":"141","author":"Zadnik","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2024.102246_b0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2024.102246_b0100","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s40123-019-00217-w","article-title":"Atropine 0.01% eye drops for myopia control in American children: a multiethnic sample across three US sites","volume":"8","author":"Larkin","year":"2019","journal-title":"Ophthalmol Ther"},{"issue":"2","key":"10.1016\/j.clae.2024.102246_b0105","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","article-title":"Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2024.102246_b0110","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis","volume":"123","author":"Huang","year":"2016","journal-title":"Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2024.102246_b0115","doi-asserted-by":"crossref","first-page":"e0124535","DOI":"10.1371\/journal.pone.0124535","article-title":"Orthokeratology to control myopia progression: a meta-analysis","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clae.2024.102246_b0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/ICL.0000000000000207","article-title":"Myopia control: a review","volume":"42","author":"Walline","year":"2016","journal-title":"Eye Contact Lens"},{"issue":"7","key":"10.1016\/j.clae.2024.102246_b0125","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1167\/iovs.11-8453","article-title":"Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study","volume":"53","author":"Hiraoka","year":"2012","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"3","key":"10.1016\/j.clae.2024.102246_b0130","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ophtha.2014.09.028","article-title":"Myopia control during orthokeratology lens wear in children using a novel study design","volume":"122","author":"Swarbrick","year":"2015","journal-title":"Ophthalmol"},{"issue":"3","key":"10.1016\/j.clae.2024.102246_b0135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/cxo.12666","article-title":"Optical and pharmacological strategies of myopia control","volume":"101","author":"Kang","year":"2018","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.clae.2024.102246_b0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/02713680590907256","article-title":"The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control","volume":"30","author":"Cho","year":"2005","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.clae.2024.102246_b0145","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1471-2415-14-141","article-title":"The control effect of orthokeratology on axial length elongation in Chinese children with myopia","volume":"14","author":"Zhu","year":"2014","journal-title":"BMC Ophthalmol"},{"issue":"10","key":"10.1016\/j.clae.2024.102246_b0150","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1167\/iovs.13-12527","article-title":"Myopia control using toric orthokeratology (TO-SEE study)","volume":"54","author":"Chen","year":"2013","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"8","key":"10.1016\/j.clae.2024.102246_b0155","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/OPX.0000000000001410","article-title":"A 3-year randomized clinical trial of MiSight lenses for myopia control","volume":"96","author":"Chamberlain","year":"2019","journal-title":"Optom vis Sci"},{"key":"10.1016\/j.clae.2024.102246_b0160","unstructured":"CooperVision, Start managing your child\u2019s myopia today, 2023. https:\/\/misight.com\/learn-about-myopia. (Accessed 23 June 2023)."},{"key":"10.1016\/j.clae.2024.102246_b0165","unstructured":"U.S.F.D. Administration, FDA approves first contact lens indicated to slow the progression of nearsightedness in children, 2023. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-contact-lens-indicated-slow-progression-nearsightedness-children. (Accessed 23 June 2023)."},{"issue":"1","key":"10.1016\/j.clae.2024.102246_b0170","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3341\/kjo.2022.0125","article-title":"Peripheral defocus and myopia management: a mini-review","volume":"37","author":"Erdinest","year":"2023","journal-title":"Korean J Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2024.102246_b0175","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/opo.12621","article-title":"Myopia control with novel central and peripheral plus contact lenses and extended depth of focus contact lenses: 2 year results from a randomised clinical trial","volume":"39","author":"Sankaridurg","year":"2019","journal-title":"Ophthalmic Physiol Opt"},{"issue":"6","key":"10.1016\/j.clae.2024.102246_b0180","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s40123-022-00562-3","article-title":"Cost-Effectiveness of presbyopia correction among seven strategies of bilateral cataract surgery based on a prospective single-blind two-center trial in China","volume":"11","author":"Lan","year":"2022","journal-title":"Ophthalmol Ther"},{"issue":"11","key":"10.1016\/j.clae.2024.102246_b0185","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.OPX.0000145028.53923.67","article-title":"Normal eye growth in emmetropic schoolchildren","volume":"81","author":"Zadnik","year":"2004","journal-title":"Optom vis Sci"},{"key":"10.1016\/j.clae.2024.102246_b0190","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.2147\/OPTH.S370041","article-title":"Reduction of myopic progression using a multifocal soft contact lens: a retrospective cohort study","volume":"16","author":"Cooper","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"8","key":"10.1016\/j.clae.2024.102246_b0195","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.3390\/jcm9082371","article-title":"The combined effect of low-dose atropine with orthokeratology in pediatric myopia control: review of the current treatment status for myopia","volume":"9","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2020","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.clae.2024.102246_b0200","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1159\/000519629","article-title":"Treatment of rapid progression of myopia: case series and literature review","volume":"12","author":"Erdinest","year":"2021","journal-title":"Case Rep Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2024.102246_b0205","doi-asserted-by":"crossref","first-page":"73.e","DOI":"10.3390\/vision6040073","article-title":"Low-concentration atropine monotherapy vs. combined with misight 1 day contact lenses for myopia management","volume":"6","author":"Erdinest","year":"2022","journal-title":"Vision (Basel)"},{"issue":"5","key":"10.1016\/j.clae.2024.102246_b0210","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/OPX.0000000000001884","article-title":"Effect of combining 0.01% atropine with soft multifocal contact lenses on myopia progression in children","volume":"99","author":"Jones","year":"2022","journal-title":"Optom Vis Sci"},{"issue":"11","key":"10.1016\/j.clae.2024.102246_b0215","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/polym10111221","article-title":"Strategies for improving ocular drug bioavailability and corneal wound healing with chitosan-based delivery systems","volume":"10","author":"Irimia","year":"2018","journal-title":"Polymers (Basel)"},{"issue":"1","key":"10.1016\/j.clae.2024.102246_b0220","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5603\/OJ.2016.0005","article-title":"Drug bioavailability from topically applied ocular drops. Does drop size matter?","volume":"1","author":"J\u00fcnemann","year":"2016","journal-title":"Ophthalmol J"},{"issue":"1","key":"10.1016\/j.clae.2024.102246_b0225","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.oftal.2019.07.009","article-title":"Contact lenses as drug-delivery systems: a promising therapeutic tool","volume":"95","author":"Holgado","year":"2020","journal-title":"Arch Soc Esp Oftalmol (engl Ed)"},{"issue":"18","key":"10.1016\/j.clae.2024.102246_b0230","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.3390\/molecules26185577","article-title":"Soft contact lenses as drug delivery systems: a review","volume":"26","author":"Rykowska","year":"2021","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.clae.2024.102246_b0235","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1167\/iovs.03-0959","article-title":"Ophthalmic drug delivery through contact lenses","volume":"45","author":"Gulsen","year":"2004","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"2","key":"10.1016\/j.clae.2024.102246_b0240","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1773-2247(14)50021-4","article-title":"Review of ophthalmic drug delivery by contact lenses","volume":"24","author":"Hsu","year":"2014","journal-title":"J Drug Deliv Sci Technol"},{"issue":"5","key":"10.1016\/j.clae.2024.102246_b0245","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archopht.121.5.626","article-title":"Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge model","volume":"121","author":"Abelson","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.clae.2024.102246_b0250","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1517\/13543776.2015.1057501","article-title":"Therapeutic contact lenses: a patent review","volume":"25","author":"Dixon","year":"2015","journal-title":"Expert Opin Ther Pat"},{"issue":"9","key":"10.1016\/j.clae.2024.102246_b0255","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.3390\/nano11092328","article-title":"Novel contact lenses embedded with drug-loaded zwitterionic nanogels for extended ophthalmic drug delivery","volume":"11","author":"Wang","year":"2021","journal-title":"Nanomaterials (basel)"},{"issue":"15","key":"10.1016\/j.clae.2024.102246_b0260","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.3390\/app10155151","article-title":"Contact lenses as drug delivery system for glaucoma: a review","volume":"10","author":"Peral","year":"2020","journal-title":"Appl Sci"},{"issue":"2","key":"10.1016\/j.clae.2024.102246_b0265","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/jop.2012.0212","article-title":"Contact lenses: promising devices for ocular drug delivery","volume":"29","author":"Guzman-Aranguez","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.clae.2024.102246_b0270","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1773-2247(11)50062-0","article-title":"Controlled drug release from contact lenses: a comprehensive review from 1965-present","volume":"21","author":"White","year":"2011","journal-title":"J Drug Deliv Sci Technol"},{"issue":"7","key":"10.1016\/j.clae.2024.102246_b0275","first-page":"e27093","article-title":"Use of ketotifen fumarate-eluting daily disposable soft contact lens in management of ocular allergy: literature review and report of two cases","volume":"14","author":"Ono","year":"2022","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.clae.2024.102246_b0280","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clae.2011.12.005","article-title":"Protein deposition on contact lenses: the past, the present, and the future","volume":"35","author":"Luensmann","year":"2012","journal-title":"Cont Lens Anterior Eye"},{"issue":"3","key":"10.1016\/j.clae.2024.102246_b0285","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1556\/1846.2015.00013","article-title":"Continuous-flow synthesis and purification of atropine with sequential in-line separations of structurally similar impurities","volume":"5","author":"Dai","year":"2015","journal-title":"J Flow Chem"},{"issue":"4","key":"10.1016\/j.clae.2024.102246_b0290","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1039\/C4NP00106K","article-title":"Ester coupling reactions \u2013 an enduring challenge in the chemical synthesis of bioactive natural products","volume":"32","author":"Tsakos","year":"2015","journal-title":"Nat Prod Rep"},{"issue":"3","key":"10.1016\/j.clae.2024.102246_b0295","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jps.2600720310","article-title":"Esterase activities in adult rabbit eyes","volume":"72","author":"Lee","year":"1983","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.clae.2024.102246_b0300","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archopht.1984.01040030371041","article-title":"Enzymatic and nonenzymatic hydrolysis of D","volume":"102","author":"Mindel","year":"1984","journal-title":"L-Dipivefrin Arch Ophthalmol"},{"issue":"17","key":"10.1016\/j.clae.2024.102246_b0305","doi-asserted-by":"crossref","first-page":"16870","DOI":"10.1021\/acsnano.3c03807","article-title":"Ester bond: chemically labile yet mechanically stable","volume":"17","author":"Lei","year":"2023","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.clae.2024.102246_b0310","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2174\/1389203715666140228153801","article-title":"New extremophilic lipases and esterases from metagenomics","volume":"15","author":"L\u00f3pez-L\u00f3pez","year":"2014","journal-title":"Curr Protein Pept Sci"},{"issue":"3","key":"10.1016\/j.clae.2024.102246_b0315","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0142-9612(01)00195-8","article-title":"Plasma-induced graft polymerization of acrylic acid onto poly(ethylene terephthalate) films: characterization and human smooth muscle cell growth on grafted films","volume":"23","author":"Gupta","year":"2003","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.clae.2024.102246_b0320","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s10812-022-01394-6","article-title":"Choice of parameters for toluidine blue o colorimetric assay: influence on the determination of grafting density of anionic groups","volume":"89","author":"Rangel","year":"2022","journal-title":"J Appl Spectrosc"},{"key":"10.1016\/j.clae.2024.102246_b0325","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5539\/ijc.v7n2p143","article-title":"Photodegradation study of toluidine blue dye in aqueous solution using magnesium oxide as a photocatalyst","volume":"7","author":"Salim","year":"2015","journal-title":"Int J Chem"},{"issue":"1","key":"10.1016\/j.clae.2024.102246_b0330","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1167\/iovs.12-10989","article-title":"Broad spectrum antimicrobial activity of melimine covalently bound to contact lenses","volume":"54","author":"Dutta","year":"2013","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"3","key":"10.1016\/j.clae.2024.102246_b0335","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/diagnostics2030023","article-title":"Comparison of 1-Ethyl-3-(3-Dimethylaminopropyl) Carbodiimide based strategies to crosslink antibodies on amine-functionalized platforms for immunodiagnostic applications","volume":"2","author":"Vashist","year":"2012","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"10.1016\/j.clae.2024.102246_b0340","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1021\/ac60041a016","article-title":"Qualitative determination of carboxylic esters","volume":"22","author":"Buckles","year":"1950","journal-title":"Anal Chem"},{"issue":"4","key":"10.1016\/j.clae.2024.102246_b0345","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/jbm.a.31398","article-title":"Quantification of carboxyl groups in carbodiimide cross-linked collagen sponges","volume":"83","author":"Everaerts","year":"2007","journal-title":"J Biomed Mater Res A"},{"issue":"2","key":"10.1016\/j.clae.2024.102246_b0350","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/jbm.a.31524","article-title":"Biomechanical properties of carbodiimide crosslinked collagen: Influence of the formation of ester crosslinks","volume":"85A","author":"Everaerts","year":"2008","journal-title":"J Biomed Mater Res A"},{"issue":"2","key":"10.1016\/j.clae.2024.102246_b0355","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/(SICI)1097-4636(199711)37:2<243::AID-JBM14>3.0.CO;2-F","article-title":"Crosslinking of hyaluronic acid with water-soluble carbodiimide","volume":"37","author":"Tomihata","year":"1997","journal-title":"J Biomed Mater Res"},{"issue":"1","key":"10.1016\/j.clae.2024.102246_b0360","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2219419","article-title":"Therapeutic applications of contact lens-based drug delivery systems in ophthalmic diseases","volume":"30","author":"Zhao","year":"2023","journal-title":"Drug Deliv"},{"issue":"3","key":"10.1016\/j.clae.2024.102246_b0365","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clae.2020.03.015","article-title":"Thirty years of \u2018quiet eye\u2019 with etafilcon A contact lenses","volume":"43","author":"Efron","year":"2020","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.clae.2024.102246_b0370","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.2147\/OPTH.S332651","article-title":"Clinical comparison of a silicone hydrogel and a conventional hydrogel daily disposable contact lens","volume":"15","author":"Miller","year":"2021","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2024.102246_b0375","first-page":"897","article-title":"Lysozyme sorption in hydrogel contact lenses","volume":"40","author":"Garrett","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"60","key":"10.1016\/j.clae.2024.102246_b0380","doi-asserted-by":"crossref","first-page":"36751","DOI":"10.1039\/D0RA06681H","article-title":"Advances in chemistry and composition of soft materials for drug releasing contact lenses","volume":"10","author":"Chatterjee","year":"2020","journal-title":"RSC Adv"},{"issue":"2","key":"10.1016\/j.clae.2024.102246_b0385","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clae.2011.12.005","article-title":"Protein deposition on contact lenses: the past, the present, and the future","volume":"35","author":"Luensmann","year":"2012","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"10.1016\/j.clae.2024.102246_b0390","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1365\/s10337-010-1524-y","article-title":"LC-MS quantitative determination of atropine and scopolamine in the floral nectar of Datura species","volume":"71","author":"Boros","year":"2010","journal-title":"Chromatographia"},{"issue":"15","key":"10.1016\/j.clae.2024.102246_b0395","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1039\/C5AY00042D","article-title":"Quantification of N-hydroxysuccinimide and N-hydroxysulfosuccinimide by hydrophilic interaction chromatography (HILIC)","volume":"7","author":"Klykov","year":"2015","journal-title":"Anal Methods"},{"key":"10.1016\/j.clae.2024.102246_b0400","first-page":"155","article-title":"Reaction of protein and carbohydrates with EDC for making unique biomaterials","volume":"111","author":"Taylor","year":"2016","journal-title":"J Am Leather Chem Assoc"},{"issue":"4","key":"10.1016\/j.clae.2024.102246_b0405","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10561-019-09790-7","article-title":"The effect of different cross-linking conditions of EDC\/NHS on type II collagen scaffolds: an in vitro evaluation","volume":"20","author":"Nong","year":"2019","journal-title":"Cell Tissue Bank"},{"issue":"11","key":"10.1016\/j.clae.2024.102246_b0410","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.3390\/nano10112142","article-title":"A comprehensive review of the covalent immobilization of biomolecules onto electrospun nanofibers","volume":"10","author":"Smith","year":"2020","journal-title":"Nanomaterials (basel)"},{"issue":"4","key":"10.1016\/j.clae.2024.102246_b0415","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1017\/S0885715619000733","article-title":"Crystal structure of atropine sulfate monohydrate, (C17H24NO3)2(SO4)\u00b7(H2O)","volume":"34","author":"Kaduk","year":"2019","journal-title":"Powder Diffr"},{"issue":"3","key":"10.1016\/j.clae.2024.102246_b0420","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00709-019-01473-0","article-title":"Utilisation of toluidine blue O pH 4.0 and histochemical inferences in plant sections obtained by free-hand","volume":"257","author":"Ribeiro","year":"2020","journal-title":"Protoplasma"},{"key":"10.1016\/j.clae.2024.102246_b0425","unstructured":"Reusch W. Natural nitrogen compounds. https:\/\/chem.libretexts.org\/Bookshelves\/Organic_Chemistry\/Supplemental_Modules_(Organic_Chemistry)\/Amines\/Nomenclature_of_Amines\/Natural_Nitrogen_Compounds. (Accessed 21 July 2023)."},{"key":"10.1016\/j.clae.2024.102246_b0430","unstructured":"Zinck E. What determines the nucleophile's strength? 2015. https:\/\/socratic.org\/questions\/what-determines-the-nucleophile-s-strength. (Accessed 05 September 2023)."},{"key":"10.1016\/j.clae.2024.102246_b0435","unstructured":"Ashenhurst J. What makes a good nucleophile? 2022. https:\/\/www.masterorganicchemistry.com\/2012\/06\/18\/what-makes-a-good-nucleophile\/. (Accessed 05 September 2023)."},{"key":"10.1016\/j.clae.2024.102246_b0440","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2147\/OPTH.S141404","article-title":"In vitro release of two anti-muscarinic drugs from soft contact lenses","volume":"11","author":"Hui","year":"2017","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.clae.2024.102246_b0445","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.survophthal.2003.12.009","article-title":"Determinants of eye drop size","volume":"49","author":"Van Santvliet","year":"2004","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2024.102246_b0450","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12886-017-0473-8","article-title":"An objective assessment of the variability in number of drops per bottle of glaucoma medication","volume":"17","author":"Moore","year":"2017","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2024.102246_b0455","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0039-6257(82)90081-9","article-title":"Pharmacokinetics of topically applied ophthalmic drugs","volume":"26","author":"Shell","year":"1982","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clae.2024.102246_b0460","first-page":"28","article-title":"International contact lens prescribing in 2022","volume":"38","author":"Morgan","year":"2023","journal-title":"Contact Lens Spectrum"},{"issue":"January\/February 2024","key":"10.1016\/j.clae.2024.102246_b0465","article-title":"International contact lens prescribing in 2023","volume":"39","author":"Morgan","year":"2024","journal-title":"Contact Lens Spectrum"},{"issue":"10","key":"10.1016\/j.clae.2024.102246_b0470","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/OPX.0000000000001282","article-title":"Development of silicone hydrogel antimicrobial contact lenses with Mel4 peptide coating","volume":"95","author":"Dutta","year":"2018","journal-title":"Optom vis Sci"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048424001383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048424001383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T11:27:28Z","timestamp":1742038048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048424001383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1367048424001383"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2024.102246","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Absorption and attachment of atropine to etafilcon A contact lenses","name":"articletitle","label":"Article Title"},{"value":"Contact Lens and Anterior Eye","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clae.2024.102246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of British Contact Lens Association.","name":"copyright","label":"Copyright"}],"article-number":"102246"}}